Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - November 2016

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Dequalinium (Fluomizin®) has been accepted for restricted use in the treatment of bacterial vaginosis where the initial treatment is ineffective or not well tolerated.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - November 2016' on Email Share 'SMC Update - November 2016' on Delicious Share 'SMC Update - November 2016' on Digg Share 'SMC Update - November 2016' on Facebook Share 'SMC Update - November 2016' on reddit Share 'SMC Update - November 2016' on StumbleUpon Share 'SMC Update - November 2016' on Twitter

atomic-wealth

No Comments to “SMC Update - November 2016”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer